Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The Phenotypes of Multiple Sclerosis Differ Significantly in Relative and Excess Mortality.

European journal of neurology - 1 Apr 2025

Magyari Melinda, Elberling Frederik, Koch-Henriksen Nils

Abstract excerpt

BACKGROUND: Patients With Multiple Sclerosis (MS) Have Higher Mortality Than Matched Background Populations. We Compare Relative and Excess Mortality in MS Over the Matched Background Populations Between Primary Progressive MS (PPMS), relapsing Onset MS (ROMS), and Secondary Progressive MS (SPMS). METHODS: We included all patients from the nationwide and complete Danish MS Registry with onset 1994-2022 and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Age of Onset
Share to Denmark
Share to Multiple Sclerosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Multiple Sclerosis, Chronic Progressive

Share to Multiple Sclerosis, Relapsing-Remitting

Share to Phenotype

Share to Registries

Source

Open in PubMed Open full text

Identifiers

PMID: 40243212
DOI: 10.1111/ene.70122
PMCID: PMC12004394

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The Phenotypes of Multiple Sclerosis Differ Significantly in Relative and Excess Mortality.PMID 40243212Read ↗

COVID-19 Severity in Multiple Sclerosis: Putting Data Into ContextSemantic proximity Read ↗

Effect of late-onset on multiple sclerosis phenotype and outcome: evidence from a multi-national registry.Semantic proximity Read ↗

Associations of DMT Therapies with COVID-19 Severity in Multiple Sclerosis: An International Cohort StudySemantic proximity Read ↗

COVID-19 in Multiple Sclerosis Patients and Risk Factors for Severe InfectionSemantic proximity Read ↗

The familial risk and heritability of multiple sclerosis and its onset phenotypes: A case-control study.Semantic proximity Read ↗

Associations of DMT therapies with COVID-19 severity in multiple sclerosisSemantic proximity Read ↗

Transition to secondary progression in relapsing-onset multiple sclerosis: Definitions and risk factorsSemantic proximity Read ↗

Redefining the Multiple Sclerosis Severity Score (MSSS): The effect of sex and onset phenotype.Semantic proximity Read ↗

Molecular mechanisms associated with multiple sclerosis progression, severity and phenotypeSemantic proximity Read ↗

Serious infections in patients with relapsing and progressive forms of multiple sclerosis: A German claims data study.Semantic proximity Read ↗

Current status and future opportunities in modeling Multiple Sclerosis clinical characteristicsSemantic proximity Read ↗

Not all roads lead to the immune system: the genetic basis of multiple sclerosis severitySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.